Full Press Release Details
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Jan. 22, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fate Therapeutics Inc. (“Fate” or “the Company”) (NASDAQ: FATE) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Fate investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On January 5, 2023, Fate announced that it would be ending its partnership with Johnson & Johnson's Janssen for cell-based cancer immunotherapies and that all collaboration activities would be discontinued in the first quarter of 2023. This news caused Fate's stock price to drop by 61.5% or $6.76, closing at $4.24 per share on January 6, 2023, resulting in financial harm to investors.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising